We are Arquer Diagnostics, a dynamic, female-led and UK-based company working at the cutting-edge of cancer diagnostics. It is our mission to transform how patients are diagnosed with cancer and then monitored throughout their treatment journey. We are doing this by developing and commercialising quick, simple, non-invasive, accurate and cost-effective cancer biomarker tests. We believe no one should have to undergo unnecessary invasive and painful procedures. Our tests are based on more than 20 years’ research and use patented technology to diagnose and monitor bladder, endometrial, prostate and ovarian cancers by detecting the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) from a simple urine sample.
View Top Employees from Arquer DiagnosticsWebsite | http://www.arquerdx.com |
Revenue | $1 million |
Employees | 8 (8 on RocketReach) |
Founded | 2006 |
Phone | +44 191 516 6765 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Medical Devices, Manufacturing General, Biotechnology, Diagnostic Equipment, Manufacturing, Science and Engineering, Laboratory Services (Healthcare), Health Care, Health Diagnostics, Medical Device |
Competitors | 2BScientific Ltd., AMSBIO, TREOS BIO LIMITED |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 325413 Companies |
Looking for a particular Arquer Diagnostics employee's phone or email?
The Arquer Diagnostics annual revenue was $1 million in 2024.
Nadia Whittley is the CEO of Arquer Diagnostics.
8 people are employed at Arquer Diagnostics.
The NAICS codes for Arquer Diagnostics are [32541, 32, 3254, 325, 325413].
The SIC codes for Arquer Diagnostics are [28, 283].